COPDにおける実際の治療パターンと患者報告アウトカム（REMIND）

基本情報

NCT ID

NCT05903989

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

708

治験依頼者名

AstraZeneca

概要

This retrospective observational study aims to report distribution of the proportion of symptomatic Chronic obstructive pulmonary disease (COPD) patients classified by the COPD Assessment Test (CAT) managed with single or dual inhaler treatment using the data at cohort entry in the COPD cohort study, and treatment change and longitudinal CAT score by each inhaler treatment will also be evaluated using the data during the follow-up period.

対象疾患

依頼者（Sponsor）